A Study of Survivorship Service Capacities Among Health Care Agencies in New York City
NCT ID: NCT00578162
Last Updated: 2012-01-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
OBSERVATIONAL
2005-04-30
2009-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
To determine organizations' need for assistance to enhance services for survivors.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study of a Distress Screening and Referral Program in People With Recently Diagnosed Cancer
NCT07117461
Adolescent Survivors of Cancer or Similar Illnesses
NCT00579631
Development of a Computer Assisted Survivor Screening For Adult Survivors of Childhood Cancer
NCT00579293
Pain in Cancer Survivors
NCT00581724
Feasibility of a Self-Management + Peer Mentoring Intervention for Adolescent and Young Adult Childhood Cancer Survivors
NCT04075734
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
To determine organizations' need for assistance to enhance services for survivors.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Data about participating agencies will be collected by electronic survey. Agencies will be identified using the NYSDOH's existing mailing list of care facilities located in the five boroughs of New York City, referral databases and resource guides created by the American Cancer Society (ACS), the New York Hospital Directory.
we will screen potential agencies using our CALL SCRIPT and our AGENCY SCREENER
A cancer care facility or 'agency' is the study's unit of analysis. Data about participating agencies will be collected by electronic survey. Agencies will be identified using the NYSDOH's existing mailing list of care facilities located in the five boroughs of New York City, referral databases and resource guides created by the American Cancer Society (ACS), the New York Hospital Directory
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
we will screen potential agencies using our CALL SCRIPT and our AGENCY SCREENER
A cancer care facility or 'agency' is the study's unit of analysis. Data about participating agencies will be collected by electronic survey. Agencies will be identified using the NYSDOH's existing mailing list of care facilities located in the five boroughs of New York City, referral databases and resource guides created by the American Cancer Society (ACS), the New York Hospital Directory
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. Be a current provider of either:
* General health services (GHS), such as primary care, health education and wellness, mental health services, home health care, palliative care, or cancer screening and diagnosis;
* Cancer-specific medical treatments (CMT), such as cancer surgery, radiation, chemotherapy, hormonal therapy; experimental therapies; cancer pain and symptom management; rehabilitation services; post-treatment monitoring and surveillance; or prophylactic treatments, such as chemoprevention; or
* Any type of specialized 'post-cancer' or 'after-cancer' medical care or support services (SMC) (i.e., psychotherapeutic, relationship and family, psycho-educational,wellness and quality of life)
2. Be located within the five boroughs of New York City
3. Have been serving cancer patients for 12 months or longer, and
4. Be willing and able to identify an English-speaking representative, 21 years of age or older as its designated key informant.
Exclusion Criteria
We will use our screening questionnaire to determine where or not a given agency should be included or excluded from the study AGENCY SCREENER.
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
NYS DEPT HEALTH CANCER SVC PRO
UNKNOWN
Memorial Sloan Kettering Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
David Loundsbury, PhD
Role: PRINCIPAL_INVESTIGATOR
Memorial Sloan Kettering Cancer Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Memorial Sloan-Kettering Cancer Center
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Memorial Sloan-Kettering Web Site
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
05-048
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.